PHARMACYTE BIOTECH, INC. Share-based Payment Arrangement, Expense
PHARMACYTE BIOTECH, INC. (PMCB) reported Share-based Payment Arrangement, Expense of $100.00 thousand for the 9-month period ending 2015-01-31, per its 10-Q filed 2015-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2015-03-13
- PHARMACYTE BIOTECH, INC. share-based payment arrangement, expense for the quarter ending 2015-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. share-based payment arrangement, expense for the quarter ending 2014-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. share-based payment arrangement, expense for the quarter ending 2013-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. share-based payment arrangement, expense for the quarter ending 2013-07-31 was $1.20M, a 563.50% increase year-over-year.
- PHARMACYTE BIOTECH, INC. share-based payment arrangement, expense for fiscal 2013 was $678.71K, a 41.54% decline from fiscal 2012.
- PHARMACYTE BIOTECH, INC. share-based payment arrangement, expense for fiscal 2012 was $1.16M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | $100.00K 10-Q · filed 2015-03-13 | |||||
| 2014-10-31 | $100.00K 10-Q · filed 2014-12-15 | ||||||
| 2014-01-31 | $0.00 10-Q · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2015-03-13 | $480.00K 10-Q · filed 2014-03-17 | $1.88M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2013-10-31 | $0.00 10-Q · filed 2013-12-16 | $0.00 10-Q · filed 2014-12-15 | $480.00K 10-Q · filed 2013-12-16 | $1.88M derived: sum of 3 quarters · filed 2013-12-16 | $1.88M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2013-07-31 | $1.20M 10-Q · filed 2013-09-16 | $1.88M derived: sum of 2 quarters · filed 2013-09-16 | $1.88M derived: sum of 3 quarters · filed 2014-03-17 | $1.88M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2013-04-30 | $678.71K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $678.71K derived: sum of 2 quarters · filed 2014-03-17 | $678.71K derived: sum of 3 quarters · filed 2014-03-17 | $678.71K 10-K · filed 2013-07-29 | |||
| 2013-01-31 | $0.00 10-Q · filed 2014-03-17 | $114.53K 10-Q · filed 2013-03-26 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $460.41K 10-Q · filed 2013-03-26 | $317.26K derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-10-31 | $0.00 10-Q · filed 2013-12-16 | $164.70K 10-Q · filed 2012-12-26 | $0.00 10-Q · filed 2013-12-16 | $345.88K 10-Q · filed 2012-12-26 | $317.26K derived: sum of 3 quarters · filed 2013-12-16 | $713.73K derived: sum of 4 quarters · filed 2013-12-16 | |
| 2012-07-31 | $181.18K 10-Q · filed 2013-09-16 | $317.26K derived: sum of 2 quarters · filed 2013-09-16 | $713.73K derived: sum of 3 quarters · filed 2013-09-16 | $1.04M derived: sum of 4 quarters · filed 2013-09-16 | |||
| 2012-04-30 | $136.07K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $532.55K derived: sum of 2 quarters · filed 2013-07-29 | $855.32K derived: sum of 3 quarters · filed 2013-07-29 | $1.16M 10-K · filed 2013-07-29 | |||
| 2012-01-31 | $396.48K 10-Q · filed 2013-03-26 | $719.24K derived: sum of 2 quarters · filed 2013-03-26 | $1.02M 10-Q · filed 2013-03-26 | ||||
| 2011-10-31 | $322.76K 10-Q · filed 2012-12-26 | $628.33K 10-Q · filed 2012-12-26 | |||||
| 2011-07-31 | $305.56K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |